Marizyme (MRZM, $0.09) was one of top quarterly gainers, jumping +2 to $0.09 per share. A.I.dvisor analyzed 904 stocks in the Biotechnology Industry over the last three months, and discovered that of them (3) charted an Uptrend while of them (6) trended down.